Gilbert Kliman

Bio

Gil joined InterWest in 1996. As a leader of InterWest’s Healthcare investment team, he invests in a broad array of healthcare opportunities, with a special interest in ophthalmology, digital health, and AI/robotics. Gil pioneered InterWest’s highly successful ophthalmology franchise. He was an early investor in Avedro, Glaukos, LenSx, and IntraLase, category-creating ophthalmic companies that became standard-of-care for eye surgery around the world. As a successful digital health investor, Gil built this important franchise for InterWest over the last twenty years through multiple companies. He led the Series A of Epocrates, the industry-leading first mobile application for physicians, serving on the board through its 2011 IPO, and was the founding institutional investor in Doximity, helping to build it into the leading physician social network engaging over 70% of U.S. physicians with over one million total users. He is a board member of Doximity, and a former board member and lead investor in Avedro (NASDAQ: AVDR, acquired by Glaukos), Glaukos (NYSE: GKOS), LenSx Lasers (acquired by Alcon), IntraLase (NASDAQ: ILSE, acquired by AMO), Restoration Robotics (NASDAQ: VERO, aquired by Venus Concept), Neuronetics (NASDAQ: STIM) and GoCheck. Gil serves on the board of Orbis International, a global not-for-profit organization focused on preventing blindness. He is also a Co-Founder and Program Director of Eyecelerator, an ophthalmology innovation conference supported by a joint venture of the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery. Previously, he helped to launch the Ophthalmology Innovation Summit (OIS), an ophthalmology business conference where he was an Advisor and Founding Co-Chairman from 2009 to 2019. A former practicing ophthalmologist, Gil completed an ophthalmology residency at Wills Eye Hospital and a retina fellowship at Massachusetts Eye and Ear Infirmary as a Heed Foundation fellow. Representative Prior Investments: Avedro (AVDR; acquired by Glaukos), Epocrates (EPOC; acquired by Athenahealth), INC Research (acquired by Avista Capital Partners), Inspire Pharmaceuticals (ISPH), IntraLase (ILSE; acquired by AMO), LenSx Lasers (acquired by Alcon), Spinal Dynamics (acquired by Medtronic), Spiration (acquired by Olympus Medical Systems)